{"id":"W4362591364","doi":"10.1016/s1556-0864(23)00281-2","title":"27P Amivantamab versus alternative real-world anti-cancer therapies in patients with advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations in the US and Europe","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Hazard ratio; Cohort; Proportional hazards model; Osimertinib; Epidermal growth factor receptor; Cancer; Confidence interval; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009968332,0.0001652475,0.0005205644,0.000284058,0.0001647263,0.0008686967,0.0001964604,0.0004943635,0.001115435],"category_scores_gemma":[0.001458895,0.00009425467,0.0007410171,0.0004101979,0.0003615759,0.0005890867,0.0003068481,0.0007563672,0.00008361651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00103325,"about_ca_system_score_gemma":0.0006229162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001460828,"about_ca_topic_score_gemma":0.004427285,"domain_scores_codex":[0.9994115,0.0003078976,0.00004131482,0.00008842833,0.00005384852,0.00009705999],"domain_scores_gemma":[0.9996185,0.000156544,0.00008385845,0.00001312165,0.00002115474,0.0001067187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2850904,0.002099654,0.3236309,0.0008027466,0.006114652,0.001336304,0.0005297863,0.00573473,0.01021018,0.002491657,0.006009047,0.35595],"study_design_scores_gemma":[0.02590108,0.05864402,0.868992,0.0005935282,0.005301008,0.003386477,0.001415517,0.007317917,0.002451913,0.00220699,0.02369045,0.00009918776],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873372,0.01007183,0.00008073117,0.0006361833,0.000112876,0.00001564081,0.0001434784,0.000006055097,0.001596035],"genre_scores_gemma":[0.9978326,0.001404915,0.00007397969,0.0003083413,0.00004349133,0.000009386896,0.0001578584,0.000002526371,0.0001668938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001460828,"threshold_uncertainty_score":0.007496774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02023484781080659,"score_gpt":0.3904648894945895,"score_spread":0.3702300416837829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}